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Abstract 
Congenital anomalies occur more commonly in infants born to diabetic 
mothers, and cardiac defects predominate. Although respiratory problems are 
also frequently found in those infants, they need to be differentiated from 
cardiovascular problems that such patients may also have, which include 
cardiovascular maladaptation to extra-uterine life, congenital heart defects 
and hypertrophic septal cardiomyopathy. A high index of suspicion is required 
as the specific management may vary and digoxin, or inotropic agents which 
may be used in heart failure associated with structural heart defects are 
contraindicated if hypertrophic cardiomyopathy is present. This article reviews 
the epidemiology, pathophysiology, clinical presentation, prognosis and 
available diagnostic and therapeutic modalities. The need for antenatal fetal 
echocardiography in pregnant diabetic mothers is also reviewed, as well as 
the controversial role of maternal glycemic control in the prevention of these 
anomalies. 
MeSH: Diabetes mellitus, Pregnancy, Newborn, Heart defects, congenital, 
Hypertrophic cardiomyopathy 
 
Introduction 
The risk of congenital anomalies is increased in infants of diabetic mothers 
(IDM), and is estimated to be between 2.5 to 12%, with an over-
representation of congenital heart defects.1,2 The incidence of malformations 
is the highest in the group where mothers were on insulin at the time of 
conception.1 IDMs often develop respiratory problems which need to be 
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differentiated from the cardiovascular problems they are prone to have 
(structural congenital heart defect and hypertrophic cardiomyopathy) and from 
cardiovascular maladaptation to extra-uterine life which they may also 
suffer.3,4 
1. Structural cardiac malformations  
Congenital heart disease occurs in 5% of IDM. The highest relative risk for 
major cardiovascular defects occurs if the mother has gestational diabetes 
and develops insulin resistance in the 3rd trimester. It is thought that maternal 
diabetes, via its effects on maternal metabolism, is responsible for the 
increase of malformations in the offspring.5 However, using hemoglobin A1c 
values as an indicator of maternal diabetic control, other studies have shown 
that congenital heart disease in the fetus is not significantly related to 
maternal diabetic control.6 The most frequent cardiac anomalies in IDMs 
include ventricular septal defect, transposition of great arteries and aortic 
stenosis. Defects involving the great arteries, including truncus arteriosus and 
double outlet right ventricle, are also more prevalent in IDMs.7,8 
The clinical presentation, diagnostic approach and therapy depend on the 
type of structural heart disease present, and are no different from when they 
occur in neonates born to non-diabetic mothers. 
2. Cardiovascular adaptation to extrauterine life  
In IDM with respiratory distress, the right ventricular pre-ejection period to 
ventricular ejection time ratio is elevated, suggesting an abnormality of the 
transitional pulmonary circulation.3 The closure of the ductus arteriosus and 
postnatal decrease in pulmonary artery pressure are also delayed in these 
neonates.4 This may partially explain the frequent occurrence of respiratory 
problems and the slowness of the recovery in such infants. Primary 
pulmonary hypertension may be associated with and aggravated by the 
polycythemia which is also frequently present in these neonates. 
3. Hypertrophic cardiomyopathy  
3.1 While symptomatic hypertrophic cardiomyopathy (HC) occurs in 12.1% of 
IDM, when routinely searched for with an echocardiographic scan it is found in 
30%.9 The left ventricular mass and contractility are increased and there is left 
ventricular outflow tract (LVOT) obstruction with apposition of the anterior 
leaflet of the mitral valve to the interventricular septum during systole. Cardiac 
output is significantly reduced, secondary to reduced stroke volume and is 
directly related to the degree of septal hypertrophy.10 This asymmetric septal 
enlargement, with a disproportionally hypertrophic septum, is an anabolic 
result of fetal hyperinsulinemia triggered by maternal hyperglycemia during 
the third trimester. Cardiac septum hypertrophy correlates with maternal 
glycosylated haemoglobin levels and high levels of fetal insulin better than 
with macrosomia (fig. 1). 
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Figure 1 Large hypotonic infant of diabetic mother, lying in a frog-like position, 
with some bruising of the left arm due to shoulder dystocia 
 
 
3.2 The severity of IDM cardiomyopathy can vary from an incidental finding on 
echocardiography (30% of cases) to an infant with severe symptoms of 
congestive heart failure (12% of cases).11 HC is usually benign and consists 
of systolic murmur and transitory cardiomegaly. All symptoms usually 
spontaneously regress within a few weeks. Sometimes, overt congestive 
heart failure develops, with tachypnea, tachycardia, gallop rhythm and 
hepatomegaly. 
3.3 Cardiomegaly is invariably present radiologically when HC is symptomatic, 
with pulmonary congestion (fig. 2). The electrocardiographic findings are not 
usually helpful. 
 
Figure 2 Chest X-ray showing significant cardiomegaly and pulmonary venous 
congestion as a result of hypertrophic cardiomyopathy in an infant of diabetic 
mother 
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Echocardiography is essential for the diagnosis of HC, it will also assess the 
left ventricular function, the degree of LVOT obstruction and it will also rule 
out structural cardiac malformations. The echocardiographic features of 
hypertrophic subaortic stenosis are well described (fig. 3).3,12,13 The left 
ventricular mass is significantly greater, with the interventricular septum being 
significantly thicker (mean (SD) 4.77 (1.4) mm) when compared with those 
born to non-diabetic mothers (2.5 (0.7) mm).14 
 
Figure 3 Two-dimensional echocardiogram showing septal hypertrophy which 
partially obstructs the left ventricular outflow tract in hypertrophic 
cardiomyopathy 
 
 
3.4 The natural history of HC is that of spontaneous regression of symptoms 
and septal hypertrophy.15 Most of the infants need only supportive care, with 
fluid restriction, diuretics and oxygen. Digoxin and inotropes are 
contraindicated as they increase LVOT obstruction. If pharmacologic 
intervention is deemed necessary, beta adrenergic blocking agents such as 
propranolol, are the drugs of choice, as they reduces heart rate, left 
ventricular contractility and wall stress, with total relief of symptoms obtained 
with standard doses of propranolol in 30% of affected infants.15,16 
3.5 The natural history of HC is benign, with resolution of symptoms within 
two to four weeks and resolution of septal hypertrophy during the first 2 to 12 
months of life, irrespective of therapy.14,15 Early or progressive hypertrophy of 
the LV posterior wall is a predictor of poor outcome, regardless of associated 
disease.17 
 
Antenatal diagnosis 
With congenital heart disease occuring in up to 5% of fetuses of diabetic 
mothers, and with 90% of the cardiac lesions identifiable prenatally, it has 
been suggested that detailed fetal echocardiography is offered to all diabetic 
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women during pregnancy.18–22 However, when studied in relation to maternal 
initial HbA1c, the overall sensitivity for identifying congenital heart disease 
was 50% and specificity 54% and no critical level of HbA1c that provided 
optimal predictive power for congenital heart disease screening was 
identified.23 It has also been suggested that the fetal cardiac septum thickness 
should be measured in utero by sonocardiography in all diabetic 
pregnancies.24 
 
Prevention 
Careful management of diabetes in pregnancy may reduce the severity of 
hypertrophic cardiomyopathy.11,25 However, other studies found no 
relationships between the echocardiographic results and the metabolic control 
of pregnancy or fetal characteristics, suggesting that strict maternal diabetes 
control may not prevent accelerated fetal cardiac growth and abnormal 
development of cardiac function.26,27 
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